Market Research Logo

The World Market for Molecular Diagnostics Update (Microbiology, Histology, Blood Screening, Prenatal, Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics, CTCs)

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. Many molecular tests are CE Marked and FDA-cleared and many more are in development.  However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology.   

In light of the amount of activity in test development and regulatory and reimbursement challenges in 2013, Kalorama Information presents this updated review of molecular diagnostics with an emphasis on the last six months of 2013: July – December.   This report highlights trends and developments that portent the evolution of molecular tests and technologies.  The ensemble of consumer demand, technological advances and market forces create a dynamic, energetic and fast-moving environment for new tests and companies.  

Though focused on the developments of the last six months, coverage is substantial.  As part of its coverage, this report provides, current market size and forecasts for Molecular Diagnostic Segments, including:

-Microbiology
-Histology
-Blood Screening
-Prenatal
-Coagulation
-Inherited Diseases
-Tissue Typing
-Cancer Markers
-Pharmacodiagnostics
- CTCs


The report provides breakout of key market segments for molecular diagnostic markets in world regions, including developed nations and emerging nations.     In addition the following important trend information is also provided:  

-Selected Sequencing-Based Innovations July-December 2013
-Selected Molecular Diagnostics Collaborations, July-December 2013       
-Selected Molecular Diagnostics Licensing Agreements, July-December 2013      
-Selected Molecular Diagnostics Distribution Agreements, July-December 2013  
-Regulatory and Reimbursement Update
-Molecular Test Revenues of The Top Companies, 2012-2013       

Market analysis in this report covers world markets for in vitro diagnostics, however the reader will find a bias toward the developed areas of the globe -- North America and Western Europe.  However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases. The information presented in this report is derived primarily from company reports and other publicly available information published by government, and medical organizations.  


  • Market Overview
    • BACKGROUND
    • SCOPE AND METHODOLOGY
      • Table Exchange Rate Fluctuations, 2009-2013
    • SIZE AND GROWTH OF THEMARKET,WORLDWIDE
      • Table Worldwide Molecular Test Sales, 2012-2013, by test segment (Sales $ millions)
      • Table Worldwide Molecular Test Sales, 2012-2013, by geography (North America, Western Europe, Japan, China, Latin America, ROW) (Sales $ millions)
    • REGULATORY AND REIMBURSEMENT UPDATE
      • Table Selected advanced test innovations July -December 2013
    • COMPANY MOVES
      • Table Selected Company Purchases And Joint Ventures July-December 2013
      • Table Selected collaborations July-December 2013
      • Table Selected licensing agreements July-December 2013
      • Table Selected distribution agreements July-December 2013
    • TOP SUPPLIERS AND NICHE PLAYERS
      • Table Molecular Test Revenues Of The Top Companies, 2012-2013 $ million (estimated)
    • TEST SERVICES CONTINUE TO EXPAND
      • Table Selected Molecular Test Services, Sales 2012-2013 ($ millions, estimated)
      • Table Selected Molecular Test Services July-December 2013
    • POINT OF VIEW
  • Sequencing Moves To The Clinic
    • BACKGROUND
      • Table Major Sequencing Platforms
    • CANCER GETS MORE PERSONAL
    • PATHOGEN SEQUENCING
      • Table Selected Sequencing-Based Innovations July-December 2013
  • The Market For Blood-Based Markers In Cancer
    • BACKGROUND
    • BLOOD-BASED ANALYSES
      • Table Selected Innovation In Blood-Based Cancer Tests July-December 2013
      • Table Selected Non-Invasive Molecular Cancer Tests In Development July-December 2013
    • CIRCULATING TUMOR CELLS
      • Table Selected Innovations In Circulating Tumor Cell Testing July-December 2013
  • The Market For Molecular Assays In Hematology
    • BACKGROUND
      • Table Selected Innovations In Molecular Hematological Tests July-December 2013
  • The Market For Molecular Assays In Coagulation And Cardiac Care
    • BACKGROUND
    • COAGULATION MARKET ANALYSIS
      • Table Selected Tests For Coagulation And Cardiac Disease Molecular Markers July-December 2013
  • The Market For Molecular Assays In Histopathology/Cytology
    • BACKGROUND
      • Table Worldwide Molecular Histology/Cytology Sales, 2012-2013 (Sales $ million)
    • MOLECULAR HISTOLOGY
      • Table Selected Molecular Histology Innovations July-December 2013
    • Market Analysis
      • Table Selected Innovations In Molecular Tissue Sample Preparation July - December 2013
    • HPV TESTING
      • Table Selected Innovations In HPV Testing July -December 2013
  • The Market For Molecular Assays In Microbiology/Virology
    • OVERVIEW
      • Table Molecular Test Sales, Microbiolog/Virology, 2012-2013 ($ Millions)
    • HIV/AIDS
    • HEPATITIS
      • Table Selected Hepatitis Test Innovations July-December 2013
    • SEXUALLY TRANSMITTED DISEASES
      • Table Selected Innovations In Molecular STD Testing July-December 2013
    • HOSPITAL ACQUIRED INFECTIONS
      • Table Selected Molecular HAI Test Innovations July-December 2013
    • RESPIRATORY TRACT INFECTIONS
      • Table Selected Respiratory Tract Test Innovations July-December 2013
    • TUBERCULOSIS
    • BLOOD CULTURE
    • MISCELLANEOUS
      • Table Selected Microbiology Innovations July-December 2013
    • MASS SPECTROMETRY
  • The Market For Molecular Assays In Blood Transfusion Screening
    • BACKGROUND
    • BLOOD PATHOGEN SCREENING
    • BLOOD TYPING
  • The Market For Molecular Assays For Inherited Diseases
    • Table Selected Innovations In Molecular Tests For Inherited Diseases July - December 2013
  • The Market For Molecular Assays In Organ Transplant Management
  • The Market For Molecular Assays In Prenatal And Neonatal Testing
    • Table Selected Innovations In Prenatal Testing July-December 2013
  • Forecast: An Eye For The Next Six Months - January To June 2014

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report